Quantcast
 
New ETF Book by Larry Connors - Click here to read more


SGP

SGP hits 52-week high at 25.29 - 07/02 - 09:03 AM ET

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa - 07/01 - 09:00 AM ET

Schering-Plough Corporation (SGP) Corporate Event Announcement Notice - 06/29 - 09:00 PM ET

Schering-Plough Schedules Conference Call Webcast for 2009 Second Quarter Earnings - 06/29 - 11:14 AM ET

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis - 06/26 - 05:00 AM ET

New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus - 06/23 - 02:00 PM ET

Schering Plough and Tekscan Partner to Deliver Foot Orthotics - 06/18 - 03:04 AM ET

The New York Yankees' Mark Teixeira, National Foundation For Cancer Research, and the Makers of COPPERTONE SPORT(R) Launch 'Help Strike Out Sun Damage' Program - 06/17 - 07:47 AM ET

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives - 06/10 - 01:00 AM ET

Alder Biopharmaceuticals expands collaboration with Schering-Plough - 06/09 - 01:04 PM ET

Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough - 06/08 - 08:30 AM ET

Schering-Plough files European MAA for antipschycotic drug - 06/04 - 01:15 PM ET

Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder - 06/02 - 03:00 AM ET

Adult Glioblastoma: Best Approaches to a Challenging Diagnosis - 06/01 - 11:01 AM ET

Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males - 05/19 - 07:37 AM ET

Photos: Schering-Plough Introduces DR. SCHOLL'S(R) FOR HER High Heel Insoles to Help Prevent Foot Aches and Pains - 05/18 - 10:27 AM ET

SGP: Conference call regarding Webcast For Annual Meeting of Shareholders @ 08:30 ET Today [delayed] - 05/18 - 07:20 AM ET

Introducing COPPERTONE(R) NutraShield(R) With Dual Defense(R), New Sunscreen Line With Antioxidants To Help Promote Natural Skin Repair - 05/14 - 07:49 AM ET

Schering-Plough initiates enrollment in Phase III study of heart drug - 05/13 - 09:00 AM ET

Schering-Plough Schedules Webcast For Annual Meeting of Shareholders - 05/11 - 08:25 AM ET

Page 1 of 11     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.